NRX-252262

N/A

Report date: 2023/12/14 18:18:38
NME

Base Information

Drug NameNRX-252262
Drug Alias NameNRX-252262
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionCatenin beta 1 inhibitorsWnt signalling pathway inhibitors
TargetsCatenin beta 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNurix Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNurix Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A